114 related articles for article (PubMed ID: 16445666)
21. CyclinD1, a prominent prognostic marker for endometrial diseases.
Liang S; Mu K; Wang Y; Zhou Z; Zhang J; Sheng Y; Zhang T
Diagn Pathol; 2013 Aug; 8():138. PubMed ID: 23947899
[TBL] [Abstract][Full Text] [Related]
22. Cyclin D1 is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients.
Khabaz MN; Abdelrahman AS; Butt NS; Al-Maghrabi B; Al-Maghrabi J
Ann Diagn Pathol; 2017 Oct; 30():47-51. PubMed ID: 28965628
[TBL] [Abstract][Full Text] [Related]
23. Expression of cyclin A, cyclin E and p27 in normal, hyperplastic and frankly malignant endometrial samples.
Gezginc ST; Celik C; Dogan NU; Toy H; Tazegul A; Colakoglu MC
J Obstet Gynaecol; 2013 Jul; 33(5):508-11. PubMed ID: 23815208
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical pattern of protein P21, cyclin D1 and cyclin E in endometrial hyperplasia.
Brucka A; Bartczak P; Ratyńska M; Sporny S
Pol J Pathol; 2009; 60(1):19-25. PubMed ID: 19670700
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of cyclin E expression in endometrial hyperplasia and cancer in postmenopausal women].
Bitner A; Zdziennicki A; Wlaźlak E; Kobos J; Suzin J; Surkont G
Ginekol Pol; 2014 Sep; 85(9):665-71. PubMed ID: 25322537
[TBL] [Abstract][Full Text] [Related]
26. Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus - correlation with proliferation and clinicopathological parameters.
Watanabe J; Sato H; Kanai T; Kamata Y; Jobo T; Hata H; Fujisawa T; Ohno E; Kameya T; Kuramoto H
Br J Cancer; 2002 Jul; 87(1):81-5. PubMed ID: 12085261
[TBL] [Abstract][Full Text] [Related]
27. The value of epithelial membrane antigen overexpression in hyperplastic and malignant endometrium and its relationship with steroid hormone receptor expression.
Kir G; Cetiner H; Gurbuz A; Karateke A
Eur J Gynaecol Oncol; 2004; 25(4):502-5. PubMed ID: 15285315
[TBL] [Abstract][Full Text] [Related]
28. p16 is consistently expressed in endometrial tubal metaplasia.
Horree N; Heintz AP; Sie-Go DM; van Diest PJ
Cell Oncol; 2007; 29(1):37-45. PubMed ID: 17429140
[TBL] [Abstract][Full Text] [Related]
29. High expression of skp2 correlates with poor prognosis in endometrial endometrioid adenocarcinoma.
Kamata Y; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Hattori M; Obokata A; Kuramoto H
J Cancer Res Clin Oncol; 2005 Sep; 131(9):591-6. PubMed ID: 16080017
[TBL] [Abstract][Full Text] [Related]
30. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
Obokata A; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Kuramoto H
Anticancer Res; 2007; 27(1A):95-105. PubMed ID: 17352221
[TBL] [Abstract][Full Text] [Related]
31. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of cyclins A, B1, D3 and E in G1 phase of the cell cycle between the synchronized and asynchronously growing MOLT-4 cells.
Yu C; Hu J; Feng Y; Tao D; Wu J; Qin J; Liu S; Zhang M; Wang G; Li X; Zhao J; Ding H; Reed E; Li QQ; Gong J
Int J Mol Med; 2005 Oct; 16(4):645-51. PubMed ID: 16142399
[TBL] [Abstract][Full Text] [Related]
33. [The cyclin A, B1, D1 and E expression in advanced non-small cell lung cancer--stages IIIB-IV (preliminary report)].
Kosacka M; Piesiak P; Porebska I; Korzeniewska A; Jankowska R
Pol Merkur Lekarski; 2011 Apr; 30(178):253-8. PubMed ID: 21595169
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical expression of heat shock protein 27, in normal hyperplastic and neoplastic endometrium: correlation with estrogen and progesterone receptor status, p53, pRb and proliferation associated indices (PCNA, MIB1).
Zagorianakou N; Ioachim E; Mitselou A; Kitsou E; Zagorianakou P; Makrydimas G; Salmas M; Agnantis NJ
Eur J Gynaecol Oncol; 2003; 24(3-4):299-304. PubMed ID: 12807244
[TBL] [Abstract][Full Text] [Related]
35. Progressive derailment of cell cycle regulators in endometrial carcinogenesis.
Horrée N; van Diest PJ; van der Groep P; Sie-Go DM; Heintz AP
J Clin Pathol; 2008 Jan; 61(1):36-42. PubMed ID: 17483252
[TBL] [Abstract][Full Text] [Related]
36. The sensitivity and specificity of a new formula to distinguish endometrioid type endometrial carcinoma from ovarian endometrial carcinoma.
Nishimura S; Ito YM; Tsuda H; Ohnishi Y; Kataoka F; Nomura H; Chiyoda T; Suzuki A; Susumu N; Aoki D; Hatae M
Eur J Obstet Gynecol Reprod Biol; 2010 Jan; 148(1):67-72. PubMed ID: 19815329
[TBL] [Abstract][Full Text] [Related]
37. Hepatocellular carcinoma cell cycle: study of Long-Evans cinnamon rats.
Masaki T; Shiratori Y; Rengifo W; Igarashi K; Matsumoto K; Nishioka M; Hatanaka Y; Omata M
Hepatology; 2000 Oct; 32(4 Pt 1):711-20. PubMed ID: 11003614
[TBL] [Abstract][Full Text] [Related]
38. Immunoexpression of Cyclin D1 and PTEN in Various Endometrial Pathologies.
Shawana S; Kehar SI; Masood S; Aamir I
J Coll Physicians Surg Pak; 2016 Apr; 26(4):277-82. PubMed ID: 27097697
[TBL] [Abstract][Full Text] [Related]
39. Cyclin D1 overexpression in primary hypopharyngeal carcinomas.
Masuda M; Hirakawa N; Nakashima T; Kuratomi Y; Komiyama S
Cancer; 1996 Aug; 78(3):390-5. PubMed ID: 8697381
[TBL] [Abstract][Full Text] [Related]
40. Alteration of G2 cell cycle regulators occurs during carcinogenesis of the endometrium.
Tsuda H; Hashiguchi Y; Inoue T; Yamamoto K
Oncology; 2003; 65(2):159-66. PubMed ID: 12931023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]